Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OxSYPan: Fluoxetine fMRI in Depressed Adolescents
NCT03436173Completed
- Sponsor
- University of Oxford
- Start
- May 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Neural activity (BOLD response) in response to angry faces at 6 hours. Started May 2012; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03436173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03436173.